dimethyl fumarate "sandoz" 120 mg enterokapsler, hårde
sandoz a/s - dimethylfumarat - enterokapsler, hårde - 120 mg
dimethyl fumarate "sandoz" 240 mg enterokapsler, hårde
sandoz a/s - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethyl fumarate "hexal" 120 mg enterokapsler, hårde
hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg
dimethyl fumarate "hexal" 240 mg enterokapsler, hårde
hexal a/s - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
formoterolfumarat "2care4" 12 mikrogram/dosis inhalationspulver
2care4 aps - formoterolfumarat - inhalationspulver - 12 mikrogram/dosis